Quarterly Confidence Sparks Momentum
Bolstering the board’s decision was a strong first-quarter showing: the company clocked $776 million in revenue, up 8.2% from the same period in 2024. CEO Eric Evans described the results as a clarion call that the firm is firing on all cylinders.
“Our performance underscores our confidence in hitting 2025 targets,” Evans stated. “Surgery Partners is strategically placed to thrive amid favorable surgical trends and a supportive regulatory environment.”
Bain Bows Out — But Not Bitterly
Though the offer was ultimately rebuffed, Bain Capital harbors no hard feelings. In a joint statement, partners Andrew Kaplan and Devin O’Reilly praised Surgery Partners’ leadership and vision, noting, “We remain tremendously optimistic about the business and look forward to continuing as long-term investors and collaborators.”
A Healthcare Empire in Motion
Founded in 2004, Surgery Partners has grown into a juggernaut, with over 200 locations across 33 states, encompassing everything from ambulatory surgery centers and surgical hospitals to physician practices and urgent care facilities.
In a time when private equity firms are circling healthcare like sharks scenting blood, Surgery Partners has chosen to swim against the tide — not into the warm arms of a buyer, but into the choppy waters of public growth, armed with sharp strategy and an unshakable sense of purpose.
